266 related articles for article (PubMed ID: 25500308)
1. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
[TBL] [Abstract][Full Text] [Related]
2. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
3. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
[TBL] [Abstract][Full Text] [Related]
4. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
6. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
Moulin V; Noordegraaf CV; Makoschey B; van der Sluijs M; Veronesi E; Darpel K; Mertens PP; de Smit H
Vaccine; 2012 Mar; 30(12):2228-35. PubMed ID: 22207091
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
[TBL] [Abstract][Full Text] [Related]
8. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
9. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
Zulu GB; Venter EH
J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
[TBL] [Abstract][Full Text] [Related]
12. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep.
Umeshappa CS; Singh KP; Pandey AB; Singh RP; Nanjundappa RH
Vaccine; 2010 Mar; 28(13):2522-31. PubMed ID: 20117268
[TBL] [Abstract][Full Text] [Related]
15. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.
Modumo J; Venter EH
J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131
[TBL] [Abstract][Full Text] [Related]
16. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
[TBL] [Abstract][Full Text] [Related]
17. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
[TBL] [Abstract][Full Text] [Related]
19. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
